Stock Research for INSM

INSM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

INSM Stock Chart & Research Data

The INSM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the INSM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


INSM Due diligence Resources & Stock Charts

The INSM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View INSM Detailed Price Forecast - CNN Money CNN View INSM Detailed Summary - Google Finance
Yahoo View INSM Detailed Summary - Yahoo! Finance Zacks View INSM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View INSM Trends & Analysis - Trade-Ideas Barrons View INSM Major Holders - Barrons
NASDAQ View INSM Call Transcripts - NASDAQ Seeking View INSM Breaking News & Analysis - Seeking Alpha
Spotlight View INSM Annual Report - CompanySpotlight.com OTC Report View INSM OTC Short Report - OTCShortReport.com
TradeKing View INSM Fundamentals - TradeKing Charts View INSM SEC Filings - Bar Chart
WSJ View Historical Prices for INSM - The WSJ Morningstar View Performance/Total Return for INSM - Morningstar
MarketWatch View the Analyst Estimates for INSM - MarketWatch CNBC View the Earnings History for INSM - CNBC
StockMarketWatch View the INSM Earnings - StockMarketWatch MacroAxis View INSM Buy or Sell Recommendations - MacroAxis
Bullish View the INSM Bullish Patterns - American Bulls Short Pains View INSM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View INSM Stock Mentions - StockTwits PennyStocks View INSM Stock Mentions - PennyStockTweets
Twitter View INSM Stock Mentions - Twitter Invest Hub View INSM Investment Forum News - Investor Hub
Yahoo View INSM Stock Mentions - Yahoo! Message Board Seeking Alpha View INSM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for INSM - SECform4.com Insider Cow View Insider Transactions for INSM - Insider Cow
CNBC View INSM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for INSM - OTC Markets
Yahoo View Insider Transactions for INSM - Yahoo! Finance NASDAQ View Institutional Holdings for INSM - NASDAQ


Stock Charts

FinViz View INSM Stock Insight & Charts - FinViz.com StockCharts View INSM Investment Charts - StockCharts.com
BarChart View INSM Stock Overview & Charts - BarChart Trading View View INSM User Generated Charts - Trading View




Latest Financial News for INSM


See what the IHS Markit Score report has to say about Insmed Inc.
Posted on Thursday September 20, 2018

This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on September 6. Index (PMI) data, output in the Healthcare sector is rising.


Pivotal Phase 3 Data from CONVERT Study of ALIS in Patients with Treatment-Refractory NTM Lung Disease Caused by MAC Published in American Journal of Respiratory and Critical Care Medicine
Posted on Monday September 17, 2018

Insmed Incorporated (INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that data from the pivotal Phase 3 CONVERT study evaluating the safety and efficacy of ALIS (amikacin liposome inhalation suspension) in adult patients with treatment-refractory nontuberculous mycobacterial (NTM) lung disease caused by Mycobacterium avium complex (MAC) were published online in the American Journal of Respiratory and Critical Care Medicine. The study showed that the addition of ALIS to guideline-based therapy (GBT) eliminated evidence of NTM lung disease caused by MAC in sputum cultures by Month 6 in 29.0% of patients (65/224), compared to 8.9% of patients (10/112) on GBT alone (p<0.0001).


Investor Expectations to Drive Momentum within Natural Resource Partners LP, Insmed, MagnaChip Semiconductor, Changyou, Pain Therapeutics, and Aurinia Pharmaceuticals — Discovering Underlying Factors of Influence
Posted on Friday August 17, 2018

NEW YORK, Aug. 17, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Natural ...


The Week Ahead: Nvidia, Retailer Earnings In Focus
Posted on Monday August 13, 2018

Below is a list of notable corporate events for the week beginning August 13. Note, this list is not comprehensive and all dates are subject to change. All times are ET. View more earnings on NTAP Monday ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.